Clinical Trial Update: Identifying Very Early Response to Seroquel Extended Release (XR) Augmentation for Major Depressive Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating very early response to quetiapine XR augmentation in adults with major depressive disorder; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SEROQUEL XR (Quetiapine)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Depressive Disorder, Major | Phase 4 | Status: COMPLETED